Figure 6From: Investigation of utilization of nanosuspension formulation to enhance exposure of 1,3-dicyclohexylurea in rats: Preparation for PK/PD study via subcutaneous route of nanosuspension drug delivery DCU nanosuspension SC dose plasma exposure simulation. Exposure versus cellular IC50 corrected for free fraction).Back to article page